IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
出版年份 2021 全文链接
标题
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
作者
关键词
-
出版物
LANCET
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-05-18
DOI
10.1016/s0140-6736(21)00520-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anticytokine Agents
- (2019) Paul M Ridker CIRCULATION RESEARCH
- Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis
- (2019) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- All roads lead to IL-6: A central hub of cardiometabolic signaling
- (2018) Peter Libby et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
- (2018) Paul M Ridker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy
- (2018) Tianxi Cai et al. JAMA Cardiology
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
- (2017) Claes Held et al. Journal of the American Heart Association
- Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial
- (2017) Christina L. Fanola et al. Journal of the American Heart Association
- From C-Reactive Protein to Interleukin-6 to Interleukin-1
- (2016) Paul M Ridker CIRCULATION RESEARCH
- Inflammation and Progression of CKD: The CRIC Study
- (2016) R. L. Amdur et al. Clinical Journal of the American Society of Nephrology
- Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial
- (2016) Ola Kleveland et al. EUROPEAN HEART JOURNAL
- IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans
- (2015) Nike Müller et al. JOURNAL OF LIPID RESEARCH
- Association of IL-6 and a Functional Polymorphism in the IL-6 Gene with Cardiovascular Events in Patients with CKD
- (2014) B. Spoto et al. Clinical Journal of the American Society of Nephrology
- Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis
- (2013) S. Kaptoge et al. EUROPEAN HEART JOURNAL
- Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC
- (2012) J. Gupta et al. Clinical Journal of the American Society of Nephrology
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Inflammation, kidney function and albuminuria in the Framingham Offspring cohort
- (2010) Ashish Upadhyay et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Association of LDL Cholesterol and Inflammation With Cardiovascular Events and Mortality in Hemodialysis Patients With Type 2 Diabetes Mellitus
- (2009) Vera Krane et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease
- (2009) Daniela V. Barreto et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now